Acuta Capital Partners’s Medicines Co MDCO Stock Holding History

Acuta Capital Partners’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-21,700	Closed	-$1.84M	–	47
2019 Q4	$1.84M	Buy	+21,700	New	+$1.45M	0.46%	32
2017 Q2	–	Sell	-70,000	Closed	-$3.42M	–	84
2017 Q1	$3.42M	Buy	+70,000	New	+$3.19M	0.81%	31

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Acuta Capital Partners's MDCO Position: Q1 2020 in Review

Acuta Capital Partners sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 21,700 shares — an estimated $1.84M sold.

Acuta Capital Partners first reported a position in MDCO in Q1 2017 and held it in 2 quarters. The position peaked at $3.42M in Q1 2017. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Acuta Capital Partners reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Acuta Capital Partners sold 21,700 Medicines Co shares in Q1 2020, an estimated $1.84M.
Acuta Capital Partners first reported a position in Medicines Co in Q1 2017 and held it in 2 quarters.
Acuta Capital Partners's Medicines Co position peaked at $3.42M in Q1 2017.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Acuta Capital Partners's 13F filing for Q1 2020, filed 15 May 2020.